The reduction in amyloid levels has been associated with a reversal of contextual memory deficits in drug-treated mice, and these data can explain how PPAR activation facilitates amyloid clearance and supports the therapeutic utility of PPAR agonists in the treatment of AD [32]. The gene discussed is PPARA; the disease is Alzheimer disease.